Skip to content
10-Q

Quarterly Report

TAXUS PHARMACEUTICALS HOLDINGS, INC.

0001549727-17-000059

← back to feed
Filed
Dec 22, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Dec 5, 2017 81.5M sh
Operating Cash Flow Q1 2018 · Sep 30, 2017 −$20
Operating Cash Flow Q1 2018 · Sep 30, 2016 −$22.44K
Cash And Equivalents Q1 2018 · Sep 30, 2017 $5.84K
Cash And Equivalents Q1 2018 · Jun 30, 2017 $5.86K
Cash And Equivalents Q1 2018 · Sep 30, 2016 $6.87K
Cash And Equivalents Q1 2018 · Jun 30, 2016 $29.31K
Stockholders Equity Q1 2018 · Sep 30, 2017 −$65.18K
Stockholders Equity Q1 2018 · Jun 30, 2017 −$53.66K
Current Liabilities Q1 2018 · Sep 30, 2017 $74.02K
Current Liabilities Q1 2018 · Jun 30, 2017 $62.52K
Current Assets Q1 2018 · Sep 30, 2017 $5.84K
Current Assets Q1 2018 · Jun 30, 2017 $5.86K
Total Assets Q1 2018 · Sep 30, 2017 $8.84K
Total Assets Q1 2018 · Jun 30, 2017 $8.86K
Sga Expense Q1 2018 · Sep 30, 2017 $12.02K
Sga Expense Q1 2018 · Sep 30, 2016 $40.52K
Net Income Q1 2018 · Sep 30, 2017 −$11.52K
Net Income Q1 2018 · Sep 30, 2016 −$39.15K
Gross Profit Q1 2018 · Sep 30, 2017 $500
Gross Profit Q1 2018 · Sep 30, 2016 $1.37K
Revenue Q1 2018 · Sep 30, 2017 $500
Revenue Q1 2018 · Sep 30, 2016 $5.49K
Cost Of Revenue Q1 2018 · Sep 30, 2016 $4.12K